Tenax Cash vs Total Current Assets Analysis

TENX Stock  USD 6.01  0.07  1.18%   
Tenax Therapeutics financial indicator trend analysis is much more than just breaking down Tenax Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tenax Therapeutics is a good investment. Please check the relationship between Tenax Therapeutics Cash and its Total Current Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenax Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.

Cash vs Total Current Assets

Cash vs Total Current Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tenax Therapeutics Cash account and Total Current Assets. At this time, the significance of the direction appears to have totally related.
The correlation between Tenax Therapeutics' Cash and Total Current Assets is 1.0. Overlapping area represents the amount of variation of Cash that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of Tenax Therapeutics, assuming nothing else is changed. The correlation between historical values of Tenax Therapeutics' Cash and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash of Tenax Therapeutics are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Cash i.e., Tenax Therapeutics' Cash and Total Current Assets go up and down completely randomly.

Correlation Coefficient

1.0
Relationship DirectionPositive 
Relationship StrengthVery Strong

Cash

Cash refers to the most liquid asset of Tenax Therapeutics, which is listed under current asset account on Tenax Therapeutics balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Tenax Therapeutics customers. The amounts must be unrestricted with restricted cash listed in a different Tenax Therapeutics account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.
Most indicators from Tenax Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tenax Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tenax Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.At this time, Tenax Therapeutics' Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 0.49 in 2024, whereas Selling General Administrative is likely to drop slightly above 4.9 M in 2024.
 2021 2022 2023 2024 (projected)
Other Operating Expenses32.7M11.1M8.2M8.4M
Depreciation And Amortization109.0K113.3K7.6K7.2K

Tenax Therapeutics fundamental ratios Correlations

-0.220.190.131.0-0.17-0.990.27-0.140.990.761.00.340.91-0.130.110.891.00.26-0.19-0.19-0.2-0.53-0.390.02-0.31
-0.22-0.04-0.04-0.260.720.280.33-0.03-0.23-0.13-0.25-0.20.17-0.17-0.430.16-0.25-0.22-0.1-0.10.730.090.35-0.160.56
0.19-0.040.830.16-0.2-0.140.05-0.130.140.330.16-0.070.11-0.170.010.380.16-0.17-0.18-0.18-0.18-0.06-0.350.05-0.06
0.13-0.040.830.11-0.29-0.1-0.190.360.10.160.10.30.010.310.250.340.11-0.03-0.33-0.33-0.230.02-0.27-0.160.02
1.0-0.260.160.11-0.2-1.00.25-0.140.990.761.00.340.9-0.120.130.871.00.27-0.18-0.18-0.23-0.53-0.40.03-0.33
-0.170.72-0.2-0.29-0.20.20.46-0.31-0.17-0.07-0.2-0.260.17-0.47-0.560.11-0.2-0.220.140.140.980.030.520.080.6
-0.990.28-0.14-0.1-1.00.2-0.220.1-1.0-0.74-1.0-0.36-0.880.09-0.16-0.85-1.0-0.280.190.190.240.520.39-0.010.34
0.270.330.05-0.190.250.46-0.22-0.530.240.280.23-0.190.47-0.62-0.930.390.23-0.270.60.60.37-0.180.270.670.45
-0.14-0.03-0.130.36-0.14-0.310.1-0.53-0.11-0.38-0.120.74-0.240.820.52-0.11-0.110.05-0.31-0.3-0.220.23-0.05-0.42-0.19
0.99-0.230.140.10.99-0.17-1.00.24-0.110.751.00.350.91-0.10.130.871.00.27-0.19-0.19-0.2-0.53-0.370.01-0.32
0.76-0.130.330.160.76-0.07-0.740.28-0.380.750.75-0.180.71-0.270.00.720.750.16-0.12-0.12-0.14-0.66-0.370.17-0.19
1.0-0.250.160.11.0-0.2-1.00.23-0.121.00.750.340.9-0.120.140.871.00.26-0.21-0.21-0.23-0.53-0.410.0-0.34
0.34-0.2-0.070.30.34-0.26-0.36-0.190.740.35-0.180.340.20.570.340.290.350.21-0.18-0.18-0.20.05-0.14-0.23-0.28
0.910.170.110.010.90.17-0.880.47-0.240.910.710.90.2-0.31-0.140.940.90.12-0.18-0.180.14-0.5-0.250.0-0.06
-0.13-0.17-0.170.31-0.12-0.470.09-0.620.82-0.1-0.27-0.120.57-0.310.62-0.19-0.10.51-0.23-0.22-0.390.150.08-0.31-0.26
0.11-0.430.010.250.13-0.56-0.16-0.930.520.130.00.140.34-0.140.62-0.070.150.37-0.68-0.68-0.48-0.02-0.42-0.67-0.58
0.890.160.380.340.870.11-0.850.39-0.110.870.720.870.290.94-0.19-0.070.870.13-0.27-0.270.09-0.46-0.29-0.04-0.02
1.0-0.250.160.111.0-0.2-1.00.23-0.111.00.751.00.350.9-0.10.150.870.27-0.21-0.21-0.23-0.52-0.41-0.01-0.34
0.26-0.22-0.17-0.030.27-0.22-0.28-0.270.050.270.160.260.210.120.510.370.130.270.040.03-0.23-0.160.270.05-0.36
-0.19-0.1-0.18-0.33-0.180.140.190.6-0.31-0.19-0.12-0.21-0.18-0.18-0.23-0.68-0.27-0.210.041.00.030.060.630.950.06
-0.19-0.1-0.18-0.33-0.180.140.190.6-0.3-0.19-0.12-0.21-0.18-0.18-0.22-0.68-0.27-0.210.031.00.030.060.620.950.06
-0.20.73-0.18-0.23-0.230.980.240.37-0.22-0.2-0.14-0.23-0.20.14-0.39-0.480.09-0.23-0.230.030.030.150.48-0.040.61
-0.530.09-0.060.02-0.530.030.52-0.180.23-0.53-0.66-0.530.05-0.50.15-0.02-0.46-0.52-0.160.060.060.150.22-0.10.14
-0.390.35-0.35-0.27-0.40.520.390.27-0.05-0.37-0.37-0.41-0.14-0.250.08-0.42-0.29-0.410.270.630.620.480.220.480.31
0.02-0.160.05-0.160.030.08-0.010.67-0.420.010.170.0-0.230.0-0.31-0.67-0.04-0.010.050.950.95-0.04-0.10.480.0
-0.310.56-0.060.02-0.330.60.340.45-0.19-0.32-0.19-0.34-0.28-0.06-0.26-0.58-0.02-0.34-0.360.060.060.610.140.310.0
Click cells to compare fundamentals

Tenax Therapeutics Account Relationship Matchups

Tenax Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets6.4M6.9M6.0M3.4M11.7M15.5M
Other Current Liab760.0K1.2M597.1K655.7K1.0M790.7K
Total Current Liabilities2.5M2.1M1.6M1.8M3.6M3.8M
Total Stockholder Equity3.8M4.6M4.2M1.5M8.1M12.7M
Property Plant And Equipment Net8.5K176.0K64.8K294.8K186.7K0.0
Net Debt(4.7M)(5.9M)(5.3M)(1.3M)(9.3M)(9.8M)
Retained Earnings(236.2M)(246.0M)(278.5M)(289.5M)(297.3M)(282.4M)
Accounts Payable1.7M757.9K859.6K448.4K2.1M2.2M
Cash4.9M6.3M5.6M2.1M9.8M9.6M
Non Current Assets Total184.4K73.2K303.2K196.2K1.1K1.1K
Cash And Short Term Investments5.4M6.7M5.6M2.1M9.8M10.0M
Common Stock Shares Outstanding309.8K6.5K12.9K18.4K248.4K260.9K
Liabilities And Stockholders Equity6.4M6.9M6.0M3.4M11.7M15.5M
Non Current Liabilities Total749.8K60.4K124.2K183.6K64.2K0.0
Other Current Assets781.0K82.6K105.1K1.1M1.9M2.0M
Other Stockholder Equity239.9M250.6M282.7M291.0M305.4M320.6M
Total Liab2.6M2.2M1.7M1.9M3.6M2.8M
Total Current Assets6.2M6.8M5.7M3.2M11.7M10.5M
Common Stock674.01.3K2.5K4.6K30.028.5
Common Stock Total Equity141.0379.0674.01.3K1.1K1.1K
Property Plant And Equipment Gross8.5K176.0K6.0K294.8K186.7K0.0
Accumulated Other Comprehensive Income(16.2K)516.0458.0(70.0)(63.0)(66.15)
Property Plant Equipment8.5K6.6K64.8K294.8K265.3K172.3K
Net Tangible Assets11.8M3.8M4.6M4.2M3.8M3.6M
Retained Earnings Total Equity(213.5M)(227.8M)(236.2M)(246.0M)(221.4M)(232.5M)
Capital Surpluse222.4M239.6M239.9M250.6M288.2M226.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tenax Stock Analysis

When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.